| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |